BioSpace News Archive

NationsHearing, LLC., a leader in the hearing healthcare industry, today announced their customer relationship management (CRM) application and the underlying supporting infrastructure has earned Certified status for information security by HITRUST.

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and full year 2018 financial results on Thursday, February 7, 2019 after the close of financial markets.

Biotech Showcase™, one of the most influential international biotechnology investor conferences in the world, concluded in San Francisco the second week of January and brought together more than 3,600 decision makers and biotech investors shaping the biopharmaceutical industry.

Masimo (NASDAQ: MASI) announced today the U.S. launch of Iris® Device Management System (Iris DMS), an automation and connectivity solution designed to streamline management of Masimo devices used throughout a hospital system.

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device, and contract research organizations, is pleased to announce a new service: LabConnect’s global sample processing network (GSPN).

Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun in a Phase III clinical study for its tocilizumab biosimilar, BAT1806.

Mobility is a basic human function yet many of our healthcare organizations operate in a culture of immobility that limits patients’ freedom to move around in space.

This is the first study of ORMD-0901 under Oramed’s existing FDA Investigational New Drug application

CarePatrol is the nation’s largest Senior Placement organization helping families find safer care options including assisted living, independent living, memory care, in-home care and nursing homes.

According to the North Carolina Mesothelioma Victims Center, “We are now offering direct access to attorney Erik Karst founding partner of the law firm Karst von Oiste for a person who has been diagnosed with mesothelioma or asbestos exposure lung cancer anywhere in North Carolina because he knows how to get his clients the best possible financial compensation results.